EUVIMEDEUVIMED entdecken
Crossref

Light/Ultrasound Dual Responsive Carbon Dots‐Based Nanovaccines for Multimodal Activation Tumor Immunotherapy of Melanoma

Aijia Yang, Li Chen, Shunxin Tang, Xiaolu Guo, Hongqin Su, Bang-Ping Jiang, Xing-Can Shen iD

Advanced Healthcare Materials · 2025

DOI: 10.1002/adhm.202405194 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Healthcare Materials, 2025. Verfasst von Aijia Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medici…. Hauptthemen laut MEDLINE: Immunotherapy, Carbon, Cancer Vaccines, Melanoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 59 Literaturangaben. Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Melanoma is a highly aggressive and metastatic tumor, and immunotherapy has become the current solution. However, conventional nanovaccines do not strongly activate T cell immune responses. Therefore, development of effective therapeutic nanovaccines to activate systemic antitumor immunity is urgently required. Herein, light/ultrasound (US) dual‐responsive carbon dot‐based nanovaccines (Cu‐N‐CDs@OVA) are designed using copper‐nitrogen‐coordinated carbon dots composited with ovalbumin. Under 650‐nm laser irradiation, Cu‐N‐CDs@OVA exhibited superior photothermal ablation of primary tumors, induced immunogenic cell death and released antigens by phototherapy, facilitating the maturation of dendritic cells (DCs). More importantly, Cu‐N‐CDs@OVA stably penetrated and diffused upon US treatment, eradicating metastatic tumors and generating low‐dose reactive oxygen species to activate DCs. By integrating with the model antigen OVA, the combined multimodal treatment promotes DC maturation to activate systematic antitumor immunity. This is the first example of a light/US dual‐responsive therapeutic nanovaccine that provides a paradigm for the production of personalized nanovaccines against malignant tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ImmunotherapyCarbonCancer VaccinesMelanomaQuantum DotsNanoparticlesAnimalsMiceDendritic CellsOvalbuminCell Line, TumorMice, Inbred C57BLFemalePhototherapyLightHumansMelanoma, ExperimentalNanovaccines

Stichwörter der Autor:innen

activation of dendritic cellscopper‐nitrogen‐coordinated carbon dotsimmunogenic cell deathlight/ultrasound dual responsiveness

Substanzen

CarbonOvalbuminCancer VaccinesNanovaccines

Autor:innen und Institutionen

  • State Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources, Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Collaborative Innovati…

ORCID-Profile: Xing-Can Shen

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Yang, A., Chen, L., Tang, S., Guo, X., Su, H., Jiang, B. P., & Shen, X. C. (2025). Light/Ultrasound Dual Responsive Carbon Dots‐Based Nanovaccines for Multimodal Activation Tumor Immunotherapy of Melanoma. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202405194

Vancouver

Yang A, Chen L, Tang S, Guo X, Su H, Jiang BP, et al. Light/Ultrasound Dual Responsive Carbon Dots‐Based Nanovaccines for Multimodal Activation Tumor Immunotherapy of Melanoma. Advanced Healthcare Materials. 2025. doi:10.1002/adhm.202405194

BibTeX
@article{Yang2025,
  author = {Yang, Aijia and Chen, Li and Tang, Shunxin and Guo, Xiaolu and Su, Hongqin and Jiang, Bang-Ping and Shen, Xing-Can},
  title = {Light/Ultrasound Dual Responsive Carbon Dots‐Based Nanovaccines for Multimodal Activation Tumor Immunotherapy of Melanoma},
  journal = {Advanced Healthcare Materials},
  year = {2025},
  doi = {10.1002/adhm.202405194}
}
Kostenlos starten →